DF/HCC Lung Cancer SPORE - CEP & DRP RFAs

November 9, 2022

DF/HCC Lung Cancer Program is seeking applications for its Lung Cancer SPORE Career Enhancement and Developmental Research Project Awards. Read more about these awards below for more information.

Career Enhancement Program RFA

The Lung Cancer Cancer Program at the Dana-Farber/Harvard Cancer Center (DF/HCC) is seeking applications for Career Enhancement Program (CEP) in Lung Cancer Research.

 

REQUEST FOR APPLICATIONS: Career Enhancement Awards in Lung Cancer Research
AWARD AMOUNT:

We anticipate awarding 2 programs in the approximate amount of $120,000 in direct costs for 18 months

APPLICATION DEADLINE: On or before January 13, 2023 at 5PM 

Eligibility: Eligible candidates for a CEP Award are those who (a) have an academic appointment as Instructor or Assistant Professor (or an equivalent entry-level position) at HMS, HSPH, MIT, BMC/BU, or St. Elizabeth’s Medical Center, or (b) are in their final year of clinical or postdoctoral fellowship at time of application and provide a job offer letter consistent with (a) (MD, PhD, or MD/PhD required). Applicants should aspire to be independent lung cancer researchers with an interest in translational investigation. The career goals of the individual may include the disciplines of basic biology, translational science, clinical science, population studies, outcomes, or social science but the proposed project must have a plan for translation into humans, since the purpose of the SPORE is to promote translational research in lung cancer. The use of the Lung SPORE Cores or DF/HCC Core resources is encouraged. A nomination letter from a senior faculty member who will serve as the applicant’s primary mentor is required, which must detail the candidate’s research and career plan, both short and intermediate term, and discuss the mentorship plan. Women and underrepresented minority (URM) candidates are strongly encouraged to apply.

Awards: Applications will be judged on the potential of the investigator to develop into a successful translational researcher, quality of mentorship plan, scientific merit, relevance to the DF/HCC Lung Cancer Program and the SPORE, and potential for extramural funding. URM status will also be considered. In this first granting period, we anticipate awarding 2 programs in the approximate amount of $120,000 in direct costs for 18 months. Funding may be used for salary and/or support of research at HMS, HSPH, or any of the Harvard-affiliated hospitals.

Expectations: Awardees are expected to become a member of the DF/HCC Lung Cancer Program if they are not already.  They applicant will be expected to attend SPORE activities (meetings, retreats, research presentations, and CEP Awardee meetings/progress updates).

Applications: A single pdf should be compiled consisting of the following:

  1. Standard format Research Plan (4 page maximum) including an Abstract, Specific Aims, Background and Relevance, Experimental Approach, Innovation & Translational Goals, and anticipated Timeline. Preliminary data are not required. Use and description of SPORE resources is encouraged. Applicants should focus on the implications of the project for future lung cancer research and the potential advances in the field that could stem from a successful outcome.
  2. A Mentorship Plan (1 page maximum) with additional detail provided in the mentor’s Nomination Letter.
  3. References and Letters of Support (not subject to the above page limit).
  4. Detailed Budget for 18 months (NIH Format) allocated as follows: $60,000 for first 6 months and $60,000 for next 12 months.
  5.  Applicant’s biosketch (NIH Format).
  6. A list of all current and recently completed grants (it is acceptable if the applicant has not had prior funding).

For applicants external to Dana-Farber Cancer Institute, please also provide:

  1. Statement of Intent (Signed)
  2. Statement of Work
  3. IRB Approval Memo (if applicable)
  4. IACUC Approval Memo (if applicable)

Applicants will have an opportunity to meet with a SPORE biostatistician for a consultation and/or to develop a brief biostatistical plan. Please email jillian_guarino@dfci.harvard.edu

Please email the single PDF file containing all materials to camanh_tran@dfci.harvard.edu and cc llimone@partners.org with your submission.

Key Dates:

Deadline for submission: January 13, 2023, by 5 pm
Funding announcement: January 30, 2023
Project/Budget period: February 1, 2023 – July 31, 2024

Hide

Developmental Research Project RFA

The Lung Cancer Cancer Program at the Dana-Farber/Harvard Cancer Center (DF/HCC) is seeking applications for Developmental Research Project Awards (DRP) in Lung Cancer Research.

 

REQUEST FOR APPLICATIONS: Developmental Research Project Awards in Lung Cancer Research
AWARD AMOUNT:

We anticipate awarding 2 programs in the approximate amount of $120,000 in direct costs for 18 months

APPLICATION DEADLINE: On or before January 13, 2023 at 5PM 

Eligibility: Eligible candidates for a DRP Award are those who (a) have a non-time limited academic faculty appointment at HMS, HSPH, MIT, BMC/BU, or St. Elizabeth’s Medical Center, or (b) are in their final year of clinical or postdoctoral fellowship at time of application and provide a job offer letter consistent with a) (MD, PhD, or MD/PhD required). The career goals of the individual and the research plan may include the disciplines of basic biology, translational science, clinical science, population studies, outcomes, or social science but the proposed project must have a plan for translation into humans, since the purpose of the SPORE is to promote translational research in lung cancer. The use of the Lung SPORE Cores or DF/HCC Core resources is encouraged. Projects may bridge SPOREs and DRP awards linked to another DRP award or SPORE project at another institution are particularly encouraged. Women and underrepresented minority (URM) candidates are strongly encouraged to apply.

Awards: High-risk, high-reward projects with rapid turn-around are encouraged. Applications will be judged on feasibility, scientific merit, relevance to the DF/HCC Lung Cancer Program and the SPORE, and potential for extramural funding. URM status will also be considered. In this first granting period, we anticipate awarding 2 programs in the approximate amount of $120,000 in direct costs for 18 months. Funding may be used for salary and/or support of research at HMS, HSPH, or any of the Harvard-affiliated hospitals.

Expectations: Awardees are expected to become members of the DF/HCC Lung Cancer Program. They will be expected to attend SPORE activities (meetings, retreats, research presentations, and DRP Awardee meetings/progress updates).

Applications: A single pdf should be compiled consisting of the following:

  1. Standard format Research Plan (4 page maximum) including an Abstract, Specific Aims, Background and Relevance, Preliminary Data, Experimental Approach, Innovation & Translational Goals, and anticipated Timeline. Use and description of SPORE resources is encouraged. Applicants should focus on the implications of the project for future lung cancer research and the potential advances in the field that could stem from a successful outcome.
  2. References and Letters of Support (not subject to the above page limit).
  3. Detailed Budget for 18 months (NIH Format) allocated as follows: $60,000 for first 6 months and $60,000 for next 12 months.
  4. Applicant’s biosketch (NIH Format).
  5. A list of all current and recently completed grants.

For applicants external to Dana-Farber Cancer Institute, please also provide:

  1. Statement of Intent (Signed)
  2. Statement of Work
  3. IRB Approval Memo (if applicable)
  4. IACUC Approval Memo (if applicable)

Applicants will have an opportunity to meet with a SPORE biostatistician for a consultation and/or to develop a brief biostatistical plan. Please email jillian_guarino@dfci.harvard.edu

Please email the single PDF file containing all materials to camanh_tran@dfci.harvard.edu and cc llimone@partners.org with your submission.

Key Dates:                          

Deadline for submission: January 13, 2023, by 5 pm
Funding announcement: January 30, 2023
Project/Budget period: February 1, 2023 – July 31, 2024

Hide